Ayala Pharmaceuticals Inc (ADXS)

[mpreorder]

I keep reading that Advaxis can't continue without dilution, that big institutional investors aren't buying because of this fear. But TL already stated how he's moving forward without dilution - he selling or licensing HER2.

This construct alone should bring in enough dollars to carry us for a long while. Once this deal is done, and I hope it's soon, the sp should rise significantly. Add a partnership for the entire platform, as stated, and it goes up even more. Add good trial results and it's off to the races.